The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the “AIRMT” Score
Clinical Rheumatology · 2025-08 · 44 (8) · 3253-3264
DOI: 10.1007/s10067-025-07495-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 02.07.2025. Verfasst von Youchao Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, School of Medicine, Shanghai Jiao Tong University, Ruijin Hospital, Shanghai, 200025, China. Hauptthemen laut MEDLINE: Myositis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Key Research and Development Project of China, National Natural Science Foundation of China, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases.
Abstract (Originalsprache)
INTRODUCTION/OBJECTIVES: Idiopathic inflammatory myopathies (IIM) accompanied with interstitial lung disease (ILD) are often rapidly progressive and associated with poor prognosis. This study aims to explore the different clinical characteristics and prognostic factors for IIM with and without ILD and to develop a simple predictive model. METHODS: We retrospectively evaluated 572 consecutive patients with IIM from January 2017 to May 2022. Clinical characteristics, comorbidities, survival outcomes, and treatments were assessed. The predictors of all-cause mortality were investigated by Cox regression analysis. An ROC curve was drawn to evaluate the predictive value of independent risk factors. RESULTS: Patients with IIM-ILD were older and exhibited more respiratory and arthritis symptoms, but fewer tumor comorbidities. The first-year survival rate was 86% for ILD and 95% for non-ILD. The mortality rate in IIM-ILD patients was higher than in non-ILD patients (15.9% vs 6.2%, P = 0.001). ILD patients were more susceptible to various types of infections (bacteria, Pneumocystis jirovecii pneumonia (PJP), fungi, cytomegalovirus, all P < 0.001) and had a higher incidence of intubation (5.1% vs 1.2%, P = 0.009). Age, respiratory failure (RF), tumor, and MDA5 antibodies were independent predictors of survival for both IIM and IIM-ILD. Then, we established the "AIRMT" score and simple "AIRMT" score, which demonstrated good predictive capabilities with an AUC of 0.816 (95% CI 0.766-0.866) and 0.791 (95% CI 0.737-0.846). CONCLUSIONS: IIM-ILD patients have higher mortality rates and are more susceptible to infections than non-ILD. This study identified various clinical features and several risk factors associated with all-cause mortality in IIM. The "AIRMT" score was constructed as a reliable survival predictor, offering valuable guidance for further research. Key Points • Patients with IIM-ILD were older and exhibited more respiratory and arthritis symptoms but had fewer tumor comorbidities. • IIM-ILDs have higher all-cause mortality rates and are more prone to infections compared to non-ILD cases. • Age, respiratory failure, tumor comorbidity, and MDA5 antibodies are identified as independent predictors of survival for both IIM and IIM-ILD patients. • We developed a practical clinical model, the "AIRMT" score, which could be a reliable and easy-to-evaluate clinical tool to predict all-cause mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, School of Medicine, Shanghai Jiao Tong University, Ruijin Hospital, Shanghai, 200025, China.
- Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Gansu, China.
- Department of Dermatology, School of Medicine, Shanghai Jiao Tong University, Ruijin Hospital, Shanghai, 200025, China. drcaohua@126.com.
- Department of Pulmonary and Critical Care Medicine, School of Medicine, Shanghai Jiao Tong University, Ruijin Hospital, Shanghai, 200025, China. shiguochao@hotmail.com.
- Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. shiguochao@hotmail.com.
Förderung
- National Key Research and Development Project of China
- National Natural Science Foundation of China
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
- Shanghai Municipal Hospital Respiratory and Critical Care Medicine Specialist Alliance
Zitieren
APA
Yu, Y., Liu, Y., Zhu, X., Ni, Y., Dai, R., Cao, H., Shi, G., & Feng, Y. (2025). The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the “AIRMT” Score. Clinical Rheumatology, 44(8), 3253-3264. https://doi.org/10.1007/s10067-025-07495-9
Vancouver
Yu Y, Liu Y, Zhu X, Ni Y, Dai R, Cao H, et al. The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the “AIRMT” Score. Clinical Rheumatology. 2025;44(8):3253-3264. doi:10.1007/s10067-025-07495-9
BibTeX
@article{Yu2025,
author = {Yu, Youchao and Liu, Yinfang and Zhu, Xuemei and Ni, Yingmeng and Dai, Ranran and Cao, Hua and Shi, Guochao and Feng, Yun},
title = {The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the “AIRMT” Score},
journal = {Clinical Rheumatology},
year = {2025},
volume = {44},
number = {8},
pages = {3253--3264},
doi = {10.1007/s10067-025-07495-9}
}
EUVIMED